Skip to content
info@ibsgranada.es
FacebookTwitterLinkedInInstagramYouTube
ibs logo.GRANADA
  • ibs.GRANADA
  • The Institute
    • The Institute
    • Organizational structure
    • Management Units
    • Economic information
    • Rehab
    • Responsible Research and Innovation (RRI)
    • Researcher Area
    • Annual Reports ibs.GRANADA
    • Webmail access
    • Transparency
  • Research
    • Own Plan ibs.GRANADA
    • Research Areas
    • Research groups
    • Clinical research
    • Collaboration network between groups of the ibs.GRANADA
    • Researcher Finder
    • Publications Search
  • Innovation
    • Innovation
    • Technology Offers
    • Clinical practice guidelines
  • international
    • International Projects Unit
    • International Projects
    • International Networks
  • Training
    • Training
    • Research Sessions
    • Conferences and Courses
    • Mentoring Program ibs.GRANADA
    • PhD Programs
    • Official University Master's Degrees
  • News
    • Calls for applications
    • News
    • Events
  • Job vacancies
    • Job vacancies
    • Human Resources Strategy for Researchers of the European Commission (HRS4R)
  • Digital Platforms

TEC16-Advanced Therapies: Differentiation, Regeneration and Cancer

Advanced Therapies and Biomedical Technologies / IBS-TEC16 / Consolidated

ibs.GRANADA  ·  Research groups
  • Information
  • Members
  • Patents
  • Publications
  • Projects

The group's research focuses on two main axes, regenerative medicine and experimental oncology, not only in the basic aspects, but also clearly translational and interdisciplinary, with application in diagnosis and therapeutic use to benefit the health of patients with highly prevalent diseases, such as degenerative diseases and cancer. This multi and interdisciplinary orientation is based on the use of knowledge in nanotechnology and nanomedicine to meet the above objectives.

Research lines

  • Therapeutic application of adult and progenitor stem cells in pathologies
  • 3D bioprinting of tumors, tumors-on-a-chip and metastasis-on-chip
  • 3D bioprinting and biotin development and generation of natural and synthetic biomaterials with application of prevalent pathologies
  • Liquid biopsy: identification of new biomarkers and extracellular vesicles characteristic of CSCs with prognostic and predictive value of response in cancer patients
  • Development of bioreactors with application in regenerative medicine
  • Development of preclinical models for new useful treatments in regenerative medicine and cancer.
  • Development of biological nanosystems based on cell membranes (noghosts)
  • Development of new medical devices for the treatment of cancer (ultrasound)
  • Development of chemical platforms for the detection of nucleic acids
  • Implementation of intelligent theranostic nanomedicines
  • Implementation of a non-invasive integrated platform based on the use of bioinformatics, nanotechnology and graphene biosensors
  • Integration of nanotechnology with dynamic chemistry as a diagnostic tool
  • New natural and synthetic drugs selective against CSCs
  • Organoids-on-a-chip
  • Role of cancer stem cells (CSCs) and their microenvironment in tumor development.
  • Cancer gene therapy: suicide genes and CAR-T systems for solid tumors
  • Use of chimeric cytokines in cell differentiation

Research networks

  • CA21108 - European Network for Skin Engineering and Modeling (NETSKINMODELS)

Keywords

stem cells, cancer stem cells, 3D bioprinting, labs-on-chip, nanoparticles, nano-ghosts, teragnosis, exosomes, liquid biopsy, gene therapy, suicide genes, bioreactors, medical devices, dynamic chemistry, biosensors

PABLO HERNANDEZ CAMARERO

ALICIA RUIZ RODRIGUEZ

  • ORCID

Ana Belen Diaz Ruano

  • ORCID

Ana Voltes Martinez

Jesus Ruiz Espigares

  • ORCID

Laura Garrido Martin

Elisa Nygren Jimenez

PAULA PLEGUEZUELOS BELTRAN

  • ORCID

MARIA BELEN TOLEDO CUTILLAS

  • ORCID

Jesus Pena Martin

  • ORCID

LAURA DE LARA PEÑA

  • ORCID

Julia Lopez de Andres

  • ORCID

Alba Hidalgo Ramirez

NIEVES CASILLAS RUIZ

  • ORCID

Giselle Xavier Reis

  • ORCID

ANDREA MORENO REVUELTA

  • ORCID

Maria Dolores Gomez Capel

AITOR GONZALEZ TITOS

  • ORCID

MARIA DEL CARMEN HERNANDEZ VALLADARES

  • ORCID

ALFONSO RUBIO NAVARRO

  • ORCID

MARIA PAZ DE LA ZAFRA MARTIN

DANIEL NIETO GARCIA

  • More Information
  • ORCID

PABLO GRAVAN JIMENEZ

  • ORCID

JUAN ANTONIO MARCHAL CORRALES

  • More Information
  • ORCID

SAUL ABENHAMAR NAVARRO MARCHAL

  • ORCID

JOSE LUIS PALACIOS FERRER

  • ORCID

ANTONIO PALOMEQUE JIMENEZ

  • ORCID

MANUEL PICON RUIZ

  • More Information
  • ORCID

GLORIA RUIZ ALCALA

  • ORCID

FRANCISCO JESUS ​​ARREBOLA VARGAS

  • More Information
  • ORCID

HOURIA BOULAIZ TASSI

  • ORCID

ESMERALDA CARRILLO SLIM

  • ORCID

MARIA EUGENIA GARCIA RUBIÑO

  • ORCID

MARIA ANGEL GARCIA CHAVES

MICHAEL HACKENBERG

  • More Information
  • ORCID

GEMA JIMENEZ GONZALEZ

  • More Information
  • ORCID

ELENA LOPEZ RUIZ

  • ORCID

MARGARITA AGUILERA GOMEZ

  • More Information
  • ORCID
Inventors: JUAN ANTONIO MARCHAL CORRALES, PAULA PLEGUEZUELOS BELTRÁN AND ELENA LÓPEZ RUIZ
Title: NOVEL FIBRINOGEN-BASED BIOINKD FOR WOUND HEALING AND TISSUE REGENERATION
Dress: EP24382364.8
Application date: 09 / 04 / 2024





Inventors: JUAN ANTONIO MARCHAL CORRALES, PAULA PLEGUEZUELOS BELTRÁN AND ELENA LÓPEZ RUIZ
Title: SYSTEM FOR PROVIDING A BIOINK IN THE FORM OF A SPRAY AND METHOD THEREOF
Dress: EP24382365.5
Application date: 09 / 04 / 2024





Inventors: HOURIA BOULAIZ TASSI, CARMEN GRIÑÁN LISÓN, YAIZA JIMÉNEZ MARTÍNEZ AND JUAN ANTONIO MARCHAL CORRALES
Title:GENE THERAPY WITH THE GENES HOKD AND LDRB
Dress: PCT/ES2022/070693
Application date: 25 / 02 / 2024





Inventors: JUAN ANTONIO MARCHAL CORRALES, MARÍA DEL CORAL DEL VAL CORRALES, Mª BELÉN GARCÍA ORTEGA AND JESÚS PEÑA MARTÍN
Title: NOVEL BIOMARKERS FOR EARLY DIAGNOSIS OF MALIGNANT MELANOMA
Dress: P202430017
Application date: 11 / 01 / 2024





Inventors: JAIME GÓMEZ MORALES, RAQUEL FERNANDEZ PENAS, ELENA LÓEZ RUIZ, ADRIANA CAROLINA TORRES MANSILLA, PEDRO DOMINGO ALVAREZ LLORET, ANA VOLTES MARTINEZ, JUAN ANTONIO MARCHAL CORRALES, CRISTOBAL VERDUGO ESCAMILLA
Title: EGG SHELL MEMBRANE MINERALIZED WITH CALCIUM PHOSPHATES FOR APPLICATIONS
Dress: PCT/ES2023/070274
Application date: 02 / 11 / 2023





Inventors: HOURIA BOULAIZ
TitleGene therapy with IDRB and HOKD genes for cancer treatment
Dress: PCT/ES2022/070693
Application date: 22 / 11 / 2022





Inventors: JUAN ANTONIO MARCHAL CORRALES
Title: HANDHELD EXTRUSION-BASED BIOPRINTING DEVICE FOR IN-SITU CORNEAL TISSUE REPAIR OR REGENERATION
Dress: P202230729
Application date: 05 / 08 / 2022





Inventors: JUAN ANTONIO MARCHAL CORRALES
TitleMETHOD OF FUNCTIONALIZATION OF POLYMERIC MATERIAL WITH PBA AND ITS USE IN BIOMEDICINE
Dress: P202230435
Application date: 20 / 05 / 2022





Inventors: JUAN ANTONIO MARCHAL CORRALES
Title: HYDROGELS FOR USE IN SKIN TISSUE ENGINEERING
Dress: P202230432
Application date: 20 / 05 / 2022





Inventors: JUAN ANTONIO MARCHAL CORRALES
Title: ANTITUMOR ACTIVITY OF POLYSACCHARIDES DERIVED FROM WHEAT CELL CULTURE
Dress: P202230419
Application date: 12 / 05 / 2022





Inventors: JUAN ANTONIO MARCHAL CORRALES
Title: EGG SHELL MEMBRANE MINERALIZED WITH CALCIUM PHOSPHATES FOR APPLICATIONS
Dress: P202230390
Application date: 28 / 04 / 2022





Inventors: JUAN ANTONIO MARCHAL CORRALES
Title:MASLINIC ACID SOLID LIPID NANOPARTICLES, PROCEDURE FOR THEIR PREPARATION AND THE USE THEREOF
Dress: P202230598
Application date: 01 / 04 / 2022





Inventors: JUAN ANTONIO MARCHAL CORRALES
Title: BIOFABRICATION OF A TRI-LAYERED 3D-BIOPRINTED CSC-BASED MALIGNANT 1 MELANOMA MODEL 2 FOR PERSONALIZED CANCER TREATMENT
Dress: EP22382096
Application date: 05 / 02 / 2022





Inventors: HOURIA BOULAIZ TASSI, JUAN A. MARCHAL, CARMEN GRIÑAN-LISON, YAIZA JIMENEZ MARTINEZ, GEMA JIMENEZ
TitleGene therapy with the HOKD and LDRB genes for the
CANCER TREATMENT
Dress: US17/611.460
Application date: 17 / 12 / 2021





Inventors: HOURIA BOULAIZ TASSI, JUAN A. MARCHAL, CARMEN GRIÑAN-LISON, YAIZA JIMENEZ MARTINEZ, GEMA JIMENEZ
TitleGene therapy with the HOKD and LDRB genes for the
CANCER TREATMENT
Dress: EP20810087.5
Application date: 09 / 12 / 2021





Inventors:HOURIA BOULAIZ TASSI, JUAN ANTONIO MARCHAL, YAIZA JIMENEZ MARTINEZ, CARMEN GRIÑAN-LISON
Title: GENE THERAPY WITH IRDB AND HOKD GENES FOR TREATMENT OF CANCER
Dress: P2021131001
Application date: 25 / 10 / 2021





Inventors: AGUILERA GÓMEZ, MARGARITA, LÓPEZ MORENO, ANA, SUAREZ GARCÍA, ANTONIO, RIVAS VELASCO, ANA, ZAFRA GÓMEZ, ALBERTO, CANTARETO MALAGÓN, SAMUEL, MONTEOLIVA SÁNCHEZ, MERCEDES, ACUÑA MORALES, INMACULADA
TitleMICROORGANISMS FOR BPA DEGRADATION AND WITH INULINASE ACTIVITY
Dress: P202130405
Application date: 06 / 05 / 2021





Inventors: MARCHAL CORRALES, CHOCARRO WRONA, JIMÉNEZ GONZÁLEZ, ANTICH ACEDO, LÓPEZ DE ANDRÉS, VOLTES MARTÍNEZ, LÓPEZ RUIZ
Title: BIO-INK FOR 3D BIOPRINTING OBTAINED FROM A DECELERIZED MATRIX
Dress: P202130097
Application date: 08 / 02 / 2021





Inventors: JUAN ANTONIO MARCHAL CORRALES
Title: BIOMATERIAL FOR USE IN THE TREATMENT OF DISEASES INVOLVING TISSUE REPAIR OR REGENERATION
Dress: P202030939
Application date: 16 / 09 / 2020





Inventors: JUAN ANTONIO MARCHAL CORRALES
Title: LDRB TOXIN FOR ANTITUMOR THERAPY.
Dress: PCT/ES2020/070315
Application date: 15 / 05 / 2020






Inventors: MARCHAL CORRALES, LOPEZ RUIZ, DÍAZ MOCHÓN, JIMÉNEZ GONZÁLEZ; PERÁN QUESADA
Title: COMPOSITION COMPRISING CHONDROCYTES ENCAPSULATED WITHIN A HYDROGEL
Application date: 09 / 03 / 2020






Inventors: CARLOS CHOCARRO WRONA, LOPEZ RUIZ ELENA
TitleHUMAN ANATOMY: LEARN BY PLAYING
Dress: RPI2001312985786
Application date: 31 / 01 / 2020


Inventors: AGUILERA GOMEZ MARGARITA; ARANEGA JIMENEZ ANTONIA; CALLEJA HERNANDEZ MIGUEL ANGEL; CARRASCO PARDO ESTHER; ESTEBAN RODRIGUEZ MARIANO; GARCIA CHAVES MARIA ANGEL; JIMENEZ GONZALEZ GEMA; MARCHAL CORRALES JUAN ANTONIO;
Title: METHOD OF OBTAINING USEFUL DATA TO ASSESS THE RESPONSE TO TREATMENT WITH 5-FLUOROURACILO (5-FU)
Code: P201130247
Application date: 24 / 02 / 2011





Inventors: ARANEGA JIMENEZ ANTONIA; BOULAIZ HOURIA; CAMPOS ROSA JOAQUIN MARIA; CATIVIELA MARIN CARLOS; CHOQUESILLO-LAZARTE DUANE; RABBIT GARCIA ANA; CRUZ LOPEZ OLGA; GARCIA CHAVES MARIA ANGEL; GARCIA RUIZ JUAN MANUEL; JIMENEZ SANZ ANA ISABEL; MARCHAL
Title: BENZOHETEROEPINE TARGETS
Code: P201030415
Application date: 22 / 03 / 2010




Inventors: A. ARANEGA; ALVAREZ DE MANZANEDA ROLDAN ENRIQUE; CHAHBOUN RACHID; F. RODRÍGUEZ SERRANO; I. MESSOURI; H. BOULAIZ; JA MARCHAL; C. MELGUIZO; M. PERÁN; J. PRADOS ;
Title: SYNTHETIC ANALOGS OF MEROSESQUITERPENES AND COMPOUNDS RELATED TO ANTI-TUMOR ACTIVITY
Code: P201050019
Application date: 30 / 12 / 2009




Inventors: JM FIELDS; LOPEZ L; MARCHAL JA; BOULAIZ H; ARANEGA A; ROOSTER MA; ESPINOSA A; RODRÍGUEZ-SERRANO F; RABBIT, ANNA
Title: NEW (RS) - 7- O 9- (1,2,3,5- TETRAHIDRO-4,1-BENZOCAZEPIN-3-IL) -7H O9H-PURINES WITH ANTI-TUMOR ACTIVITY
Code: P200802431
Application date: 07 / 08 / 2008




Inventors: ARANEGA JIMENEZ ANTONIA; CAMPOS ROSA JOAQUIN; ESPINOSA UBEDA ANTONIO; GALLO MEZO MIGUEL ANGEL; GOMEZ VIDAL JOSE ANTONIO; NUNEZ CARRETERO M DEL CARMEN; MARCHAL CORRALES JUAN ANTONIO; Rodriguez-Serrano F;
Title: (2,3-DIHYDRO-5H-1,4-BENZODIHETEROEPIN-3-IL) PURINES WITH ANTI-TUMOR ACTIVITY
Code: P200601538
Application date: 24 / 05 / 2006
Chocarro-Wrona, C; Pleguezuelos-Beltrán, P; de Andrés, JL; Antich, C; de Vicente, J; Jiménez, G; Arias-Santiago, S; Gálvez-Martín, P; López-Ruiz, E; Marchal, J.A.

A bioactive three-layered skin substitute based on ECM components effectively promotes skin wound healing and regeneration

MATERIALS TODAY BIO, 2025;

FI: 10,2; D1

Pérez-Lloret, M; Reidy, E; Lozano-Pérez, AA; Marchal, JA; Lens, NLP; Ryan, A.E.; Erxleben, A.

Auranofin loaded silk fibroin nanoparticles for colorectal cancer treatment

DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2025;

FI: 5,5; D1

Cavazza, A; Molina-Estévez, FJ; Reyes, AP; Ronco, V; Naseem, A; Malensek, S; Pecan, P; Santini, A; Heredia, P; Aguilar-González, A; Boulaiz, H; Ni, QQ; Cortijo-Gutierrez, M; Pavlovic, K; Herrera, I; de la Cerda, B; Garcia-Tenorio, EM; Richard, E; Granados-Principal, S; López-Márquez, A; Köber, M; Stojanovic, M; Vidakovic, M; Santos-Garcia, I; Blázquez, L; Haughton, E; Yan, D.N.; Sánchez-Martín, RM; Mazini, L; Aseguinolaza, GG; Miccio, A; Rio, P; Desviat, LR; Gonçalves, MAFV; Peng, L; Jiménez-Mallebrera, C; Molina, FM; Gupta, D; Lainscek, D; Luo, Y.L.; Benabdellah, K.

Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group

MOLECULAR THERAPY-NUCLEIC ACIDS, 2025;

FI: 6,1; Q1

Diaz-Ruano, AB; Gomez-Jimenez, E; Llamas-Jimenez, G; Ramirez-Muñoz, A; Espejo-Hijano, P; Rubio-Navarro, A; Picon-Ruiz, M

Advances in the use of nanoparticles for specific cell-target delivery of anti-cancer agents

LIFE SCIENCES, 2025;

FI: 5,1; Q1

Torres-Sánchez, A; Luque, G; Ortiz, P; Ruiz-Rodríguez, A; López-Moreno, A; Aguilera, M

Analysis of Human Gut Microbiota Enzymes for Biotechnological and Food Industrial Applications

FOODS, 2025;

FI: 5,1; Q1

González-Olmedo, C; García-Verdejo, FJ; Reguera-Teba, A; Rosa-Garrido, C; López-López, J.A.; Díaz-Beltrán, L.; García, PM; Luque-Caro, N; Gálvez-Montosa, F; Ortega-Granados, A.L.; Ruiz-Sanjuan, M; Cózar-Ibáñez, A; Sainz, J; Marchal, J.A.; Camacho, J; del Palacio, J.P.; Fernández-Godino, R; Díaz, C; Sánchez-Rovira, P

Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis

CLINICAL AND TRANSLATIONAL MEDICINE, 2024;

FI: 7,9; D1

Peña-Martín, J; García-Ortega, MB; Palacios-Ferrer, JL; Díaz, C; Garcia, MA; Boulaiz, H; Valdivia, J; Jury, JM; Almazan-Fernandez, FM; Santiago, SA; Vicente, F; del Val, C; del Palacio, JP; Marchal, J.A.

Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study

BRITISH JOURNAL OF DERMATOLOGY, 2024;

FI: 11; D1

Calahorra, J; Blaya-Cánovas, JL; Castellini-Perez, O; Aparicio-Puerta, E; Cives-Losada, C; Marin, J.J.G. Rementeria, M; Face, FAITH; López-Tejada, A; Griñán-Lisón, C; Aulicino, F; Berger, I; Marchal, JA; Delgado-Almenta, V; Granados-Principal, S

Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells

BIOMEDICINE & PHARMACOTHERAPY, 2024;

FI: 6,9; D1

Blaya-Cánovas, JL; Griñán-Lisón, C; Blancas, I; Marchal, JA; Ramírez-Tortosa, C; López-Tejada, A; Benabdellah, K; Cortijo-Gutiérrez, M; Cano-Cortés, MV; Graván, P; Navarro-Marchal, SA; Gómez-Morales, J; Delgado-Almenta, V; Calahorra, J; Agudo-Lera, M; Sagarzazu, A; Rodríguez-González, CJ; Gallart-Aragón, T; Eich, C; Sánchez-Martín, RM; Granados-Principal, S

Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy

MOLECULAR CANCER, 2024;

FI: 27,7; D1

de Andres, JL; Rodríguez-Santana, C; de Lara-Peña, L; Jiménez, G; Escames, G; Marchal, J.A.

A bioengineered tumor matrix-based scaffold for the evaluation of melatonin efficacy on head and neck squamous cancer stem cells

MATERIALS TODAY BIO, 2024;

FI: 8,7; D1

Lopez-Tejada, A; Grinan-Lison, C; Gonzalez-Gonzalez, A; Cara, FE; Luque, RJ; Rosa-Garrido, C; Blaya-Cananovas, JL; Navarro-Ocon, A; Valenzuela-Torres, M; Parra-Lopez, M; Calahorra, J; Blancas, I; Marchal, JA; Granados-Principal, S

TGFß Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023;

FI: 9,2; Q1

Diaz-Ruano, AB; Martinez-Alarcon, N; Perán, M; Benabdellah, K; Garcia-Martinez, MD; Preda, O; Ramirez-Tortosa, C; Gonzalez-Hernandez, A; Marchal, JA; Picon-Ruiz, M

Estradiol and Estrone Have Different Biological Functions to Induce NF-κB-Driven Inflammation, EMT and Stemness in ER plus Cancer Cells

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023;

FI: 6,208; Q1

Ruiz-Malagón, AJ; Hidalgo-García, L; Rodríguez-Sojo, MJ; Molina-Tijeras, JA; García, F; Diez-Echave, P; Vezza, T; Becerra, P; Marchal, JA; Redondo-Cerezo, E; Hausmann, M; Rogler, G; Garrido-Mesa, J; Rodríguez-Cabezas, ME; Rodríguez-Nogales, A; Gálvez, J

Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response

BIOMEDICINE & PHARMACOTHERAPY, 2023;

FI: 7,5; Q1

Garcia-Ortega, MB; Aparicio, E; Griñán-Lisón, C; Jiménez, G; López-Ruiz, E; Palacios, JL; Ruiz-Alcalá, G; Alba, C; Martínez, A; Boulaiz, H; Perán, M; Hackenberg, M; Bragança, J; Calado, SM; Marchal, JA; Garcia, MA

Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma

CANCER, 2023;

FI: 5,2; Q2

Barungi, S; Hernández-Camarero, P; Moreno-Terribas, G; Villalba-Montoro, R; Marchal, JA; López-Ruiz, E; Peran, M

Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023;

FI: 5,5; Q2

Pleguezuelos-Beltran, P; Galvez-Martin, P; Nieto-Garcia, D; Marchal, JA; Lopez-Ruiz, E

Advances in spray products for skin regeneration

BIOACTIVE MATERIALS, 2022;

FI: 16,874; D1

Grandson, D; Jimenez, G; Moroni, L; Lopez-Ruiz, E; Galvez-Martin, P; Marchal, J.A.

Biofabrication approaches and regulatory framework of metastatic tumor-on-a-chip models for precision oncology

MEDICINAL RESEARCH REVIEWS, 2022;

FI: 12,388; D1

Martinez-Moreno, D; Venegas-Bustos, D; Rus, G; Galvez-Martin, P; Jimenez, G; Marchal, J.A.

Chondro-Inductive b-TPUe-Based Functionalized Scaffolds for Application in Cartilage Tissue Engineering

ADVANCED HEALTHCARE MATERIALS, 2022;

FI: 11,092; D1

Razola-Diaz, MD; Gomez-Caravaca, AM; de Andres, JL; Voltes-Martinez, A; Zamora, A; Perez-Molina, GM; Castro, DJ; Marchal, JA; Verardo, V

Evaluation of Phenolic Compounds and Pigments Content in Yellow Bell Pepper Wastes

ANTIOXIDANTS, 2022;

FI: 7,675; D1

Gallardo, A; Molina, A; Asenjo, HG; Lopez-Onieva, L; Martorell-Marugan, J; Espinosa-Martinez, M; Grinan-Lison, C; Alvarez-Perez, JC; Face, FAITH; Navarro-Marchal, SA; Carmona-Saez, P; Medina, PP; Marchal, JA; Granados-Principal, S; Sanchez-Pozo, A; Landeira, D.

EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumor colonization

ONCOGENE, 2022;

FI: 8,756; D1

Navarro-Marchal, SA; Grinan-Lison, C; Train, JM; Ruiz-Alcala, G; Tristan-Manzano, M; Martin, F.; Perez-Victoria, I; Peula-Garcia, JM; Marchal, J.A.

Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells.

BIOMACROMOLECULES, 2021;

FI: 6,988; D1

Grinan-Lison, C; Blaya-Canovas, JL; Lopez-Tejada, A; Avalos-Moreno, M; Navarro-Ocon, A; Face, FE; Gonzalez-Gonzalez, A; Lorente, JA; Marchal, JA; Granados-Main, S

Antioxidants for the Treatment of Breast Cancer: Are We There Yet?..

ANTIOXIDANTS, 2021;

FI: 6,313; D1

Hernandez-Camarero, P; Lopez-Ruiz, E; Marchal, JA; Perán, M.

Cancer: a mirrored room between tumor bulk and tumor microenvironment

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021;

FI: 11,161; Q1

Torres-Sanchez, A; Pardo-Cacho, J; Lopez-Moreno, A; Ruiz-Moreno, A; Cerck, K; Aguilera, M.

Antimicrobial Effects of Potential Probiotics of Bacillus spp. Isolated from Human Microbiota: In Vitro and In Silico Methods.

MICROORGANISMS, 2021;

FI: 4,128; Q2

Gomez-Mateos, M; Arrebola, F; Navarro, MC; Romero, MC; Gonzalez, JM; Valero, A.

Acute Anisakiasis: Pharmacological Evaluation of Various Drugs in an Animal Model

DIGESTIVE DISEASES AND SCIENCES, 2021;

FI: 3,199; Q3

Antich, C; de Vicente, J; Jimenez, G; Chocarro, C; Carrillo, E; Montanez, E; Galvez-Martin, P; Marchal, J.A.

Bio-inspired hydrogel composed of hyaluronic acid and alginate as a potential bioink for 3D bioprinting of articular cartilage engineering constructs

BIOMATERIALIA ACT, 2020;

FI: 7,242; D1

Olivares-Urbano, MA; Grinan-Lison, C; Zurita, M; del Moral, R; Rios-Arrabal, S; Artacho-Cordon, F; Arrebola, JP; Gonzalez, AR; Leon, J; Marchal, J.A.; Nunez, MI

Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020;

FI: 4,658; Q1

Martinez, R.; Lopez-Trinidad, LM; Kapravelou, G; Arrebola, F; Galisteo, M; Aranda, P; Porres, JM; Lopez-Jurado, M.

A combined healthy strategy for successful weight loss, weight maintenance and improvement of hepatic lipid metabolism

JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2020;

FI: 4,873; Q1

Cano-Cortes, MV; Navarro-Marchal, SA; Ruiz-Blas, MP; Diaz-Mochon, JJ; Marchal, J.A.; Sanchez-Martin, R.M.

A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2020;

FI: 5,182; Q1

Oberweis, CV; Marchal, J.A.; Lopez-Ruiz, E; Galvez-Martin, P.

A Worldwide Overview of Regulatory Frameworks for Tissue-Based Products

TISSUE ENGINEERING PART B-REVIEWS, 2020;

FI: 6,089; Q1

Chocarro-Wrona, C; Lopez-Ruiz, E; Peran, M; Galvez-Martin, P; Marchal, J.A.

Therapeutic strategies for skin regeneration based on biomedical substitutes

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019;

FI: 5,113; D1

Jimenez, G; Venkateswaran, S; Lopez-Ruiz, E; Peran, M; Pernagallo, S; Diaz-Monchon, JJ; Canadas, RF; Antich, C; Oliveira, JM; Callanan, A; Walllace, R; Reis, R.L.; Montanez, E; Carrillo, E; Bradley, M; Marchal, J.A.

A soft 3D polyacrylate hydrogel recapitulates the cartilage niche and allows growth-factor free tissue engineering of human articular cartilage

BIOMATERIALIA ACT, 2019;

FI: 6,638; D1

Lopez-Ruiz, E; Jimenez, G; from Cienfuegos, LA; Antich, C; Sabata, R; Marchal, JA; Galvez-Martin, P

ADVANCES OF HYALURONIC ACID IN STEM CELL THERAPY AND TISSUE ENGINEERING, INCLUDING CURRENT CLINICAL TRIALS

EUROPEAN CELLS & MATERIALS, 2019;

FI: 3,682; D1

Contreras-Montoya, R; Escolano, G; Roy, S; Lopez-Lopez, MT; Delgado-Lopez, JM; Cuerva, JM; Diaz-Mochon, JJ; Ashkenasy, N; Gavira, JA; from Cienfuegos, LA

Catalytic and Electron Conducting Carbon Nanotube-Reinforced Lysozyme Crystals

ADVANCED FUNCTIONAL MATERIALS, 2019;

FI: 15,621; D1

Detassis, S; Grasso, M; Tabraue-Chavez, M; Marin-Romero, A; Lopez-Longarela, B; Ilyine, H; Ress, C; Ceriani, S; Erspan, M; Maglione, A; Diaz-Mochon, JJ; Pernagallo, S; Dentis, MA

New Platform for the Direct Profiling of microRNAs in Biofluids

ANALYTICAL CHEMISTRY, 2019;

FI: 6,35; D1

Hackenberg, M; Kotsyfakis, M.

Exosome-Mediated Pathogen Transmission by Arthropod Vectors

TRENDS IN PARASITOLOGY, 2018;

FI: 7,929; D1

Melchor, J; Lopez-Ruiz, E; Soto, J; Jimenez, G; Antich, C; Peran, M; Baena, JM; Marchal, J.A.; Rus, G.

In-bioreactor ultrasonic monitoring of 3D culture human engineered cartilage

B-CHEMICAL SENSORS AND ACTUATORS, 2018;

FI: 5,667; D1

Gonzalez-Gonzalez, A; Munoz-Muela, E; Marchal, JA; Face, FE; Molina, MP; Cruz-Lozano, M; Jimenez, G; Verma, A; Ramirez, A; Qian, W; Chen, W; Kozielski, AJ; Element, O; Martin-Salvago, MD; Luque, RJ; Rosa-Garrido, C; Landeira, D; Quintana-Romero, M; Rosato, RR; Garcia, MA; Ramirez-Tortosa, CL; Kim, H; Rodriguez-Aguayo, C; Lopez-Berestein, G; Sood, AK; Lorente, JA; Sanchez-Rovira, P; Chang, JC; Granados-Principal, S

Activating Transcription Factor 4 Modulates TGF beta-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2 / 3/4 and mTORC2 Signaling

CLINICAL CANCER RESEARCH, 2018;

FI: 10,199; D1

Jimenez, G; Hackenberg, M; Catherine, P; Boulaiz, H; Grinan-Lison, C; Garcia, MA; Peran, M; Lopez-Ruiz, E; Ramirez, A; Morata-Tarifa, C; Carrasco, E; Aguilera, M; Marchal, J.A.

Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile

CANCER LETTERS, 2018;

FI: 6,491; Q1

Galisteo-Gonzalez, F; Molina-Bolivar, J.A.; Navarro, SA; Boulaiz, H; Aguilera-Garrido, A; Ramirez, A; Marchal, J.A.

Albumin-covered lipid nanocapsules exhibit enhanced uptake performance by breast-tumor cells

COLLOIDS AND SURFACES B-BIOINTERFACES, 2018;

FI: 3,997; Q1

Picon-Ruiz, M; Morata-Tarifa, C; Valle-Goffin, JJ; Friedman, E.R.; Slingerland, J.M.

Obesity and Adverse Breast Cancer Risk and Outcome: Mechanistic Insights and Strategies for Intervention

CA-A CANCER JOURNAL FOR CLINICIANS, 2017;

FI: 187,04; D1

Kim, M; Jang, K; Miller, P; Picon-Ruiz, M; Yeasky, TM; El-Ashry, D; Slingerland, J.M.

VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug

ONCOGENE, 2017;

FI: 7,519; D1

Garcia-Ortega, MB; Lopez, GJ; Jimenez, G; Garcia-Garcia, JA; Count, V; Boulaiz, H; Carrillo, E; Peran, M; Marchal, JA; Garcia, MA

Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism

EXPERT REVIEWS IN MOLECULAR MEDICINE, 2017;

FI: 4,405; Q1

Lopez-Ruiz, E; Venkateswaran, S; Peran, M; Jimenez, G; Pernagallo, S; Diaz-Mochon, JJ; Tura-Ceide, O; Arrebola, F; Melchor, J; Soto, J; Rus, G; Royal, PJ; Diaz-Ricart, M; Count-Gonzalez, A; Bradley, M; Marchal, J.A.

Poly (ethylmethacrylate-co-diethylaminoethyl acrylate) coating improves endothelial repopulation, bio-mechanical and anti-thrombogenic properties of decellularized carotid arteries for blood vessel replacement

SCIENTIFIC REPORTS, 2017;

FI: 4,259; Q1

Morata-Tarifa, C; Picon-Ruiz, M; Grinan-Lison, C; Boulaiz, H; Peran, M; Garcia, MA; Marchal, J.A.

Validation of suitable normalizers for miR expression patterns analysis covering tumor heterogeneity

SCIENTIFIC REPORTS, 2017;

FI: 4,259; Q1

Navarro, SA; Carrillo, E; Grinan-Lison, C; Martina; Peran, M; Marchal, JA; Boulaiz, H

Cancer suicide gene therapy: a patent review

EXPERT OPINION ON THERAPEUTIC PATENTS, 2016;

FI: 4,626; D1

Picon-Ruiz, M; Bread, CD; Drews-Elger, K; Jang, K; Besser, A. H.; Zhao, D. K.; Morata-Tarifa, C; Kim, M; Ince, T. A.; Azzam, D.J.; Wander, SA; Wang, B; Ergonul, B; Datar, R.H.; Cote, R.J.; Howard, GA; El-Ashry, D; Torne-Poyatos, P; Marchal, J.A.; Slingerland, J.M.

Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src / Sox2 / miR-302b-Mediated Malignant Progression

CANCER RESEARCH, 2016;

FI: 8,556; D1

Lopez-Ruiz, E; Jimenez, G; Garcia, MA; Antich, C; Boulaiz, H; Marchal, J.A.; Peran, M.

Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what's new?

EXPERT OPINION ON THERAPEUTIC PATENTS, 2016;

FI: 4,626; D1

Venkateswaran, S; Luque-Gonzalez, MA; Tabraue-Chavez, M; Fara, MA; Lopez-Longarela, B; Cano-Cortes, V; Lopez-Delgado, FJ; Sanchez-Martin, R.M.; Ilyine, H; Bradley, M; Pernagallo, S; Diaz-Mochon, JJ

Novel bead-based platform for direct detection of unlabelled nucleic acids through Single Nucleobase Labeling

TALANTA, 2016;

FI: 4,035; Q1

Morata-Tarifa, C; Jimenez, G; Garcia, MA; Train, JM; Grinan-Lison, C; Aguilera, M; Picon-Ruiz, M; Marchal, JA

Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells

SCIENTIFIC REPORTS, 2016;

FI: 5,228; Q1

Carrillo, E; Navarro, SA; Ramirez, A; Garcia, MA; Grinan-Lison, C; Peran, M; Marchal, J.A.

5-Fluorouracil derivatives: a patent review (2012-2014)

EXPERT OPINION ON THERAPEUTIC PATENTS, 2015;

FI: 4,297; D1

Jimenez, G; Lopez-Ruiz, E; Kwiatkowski, W; Montanez, E; Arrebola, F; Carrillo, E; Gray, PC; Belmonte, JCI; Choe, S; Peran, M; Marchal, J.A.

Activin A / BMP2 chimera AB235 drives efficient redifferentiation of long term cultured autologous chondrocytes

SCIENTIFIC REPORTS, 2015;

FI: 5,578; D1

Villatoro, MJPDY; Unciti-Broceta, JD; Contreras-Montoya, R; Garcia-Salcedo, J.A.; Mezo, MAG; Unciti-Broceta, A; Diaz-Mochon, JJ

Amide-controlled, one-pot synthesis of tri-substituted slurries generates structural diversity and analogues with trypanocidal activity

SCIENTIFIC REPORTS, 2015;

FI: 5,578; D1

Sanchez-Moreno, P; Mailbox, P; Boulaiz, H; Peula-Garcia, JM; Ortega-Vinuesa, JL; Luke, I; Salvati, A; Marchal, J.A.

Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules

BIOMATERIALS, 2015;

FI: 8,557; D1

Roman, S; Agile, A; Peran, M; Alvaro-Galue, E; Ruiz-Ojeda, FJ; Fernandez-Vazquez, G; Marchal, J.A.

Brown adipose tissue and novel therapeutic approaches to treat metabolic disorders

TRANSLATIONAL RESEARCH, 2015;

FI: 5,03; D1

Development of biomimetic hybrid nanoparticles and their evaluation in 3D tumor models of colorectal cancer

Funder: FIBAO Foundation

File number: INTRAIBS-PI-2025-06

Execution time: 10/06/2025 - 10/06/2026

IP: SAUL ABENHAMAR NAVARRO MARCHAL

GlyNaETRUCK-12: 4th generation NanoCAR-T cells activated by the aberrant tumor glycobiome for multi-target treatment of advanced solid tumors EpCAM+

Funder: MINISTRY OF HEALTH, PRESIDENCY AND EMERGENCIES

File number: PI-0055-2025

Execution time: 25/11/2025 - 25/11/2028

PI: JUAN ANTONIO MARCHAL CORRALES

TF_2024-06 JA MARCHAL (TEC16)

Funder: FIBAO Foundation

File number: TF_2024-06

Execution time: 14/10/2024 - 31/12/2025

PI: JUAN ANTONIO MARCHAL CORRALES

Is the impact of plastic xenobiotics on childhood obesity and development irreversible? Functional role of the microbiota and its metabolites in the severity and chronicity of clinical effects.

Funder: CARLOS III HEALTH INSTITUTE - FEDER

File number: PI24 / 00046

Execution time: 01/01/2025 - 31/12/2027

PI: MARGARITA AGUILERA GOMEZ

Estrone's crucial role in the risk of developing ER+ breast cancer

Funder: CARLOS III HEALTH INSTITUTE - FEDER

File number: PI24 / 01797

Execution time: 01/01/2025 - 31/12/2027

IP: MANUEL PICON RUIZ

TF_2024-02 HOURIA BOULAIZ TASSI (TEC16)

Funder: FIBAO Foundation

File number: TF_2024-02

Execution time: 14/10/2024 - 31/12/2025

IP: HOURIA BOULAIZ TASSI

Personalized medicine through the application of targeted gene therapy to improve the diagnosis and treatment of Osteogenesis Imperfecta

Funder: MUTUA MADRILEÑA FOUNDATION

File number: FMM-AP16030-2024

Execution time: 01/07/2024 - 08/07/2027

IP: HOURIA BOULAIZ TASSI

Mass spectrometry-based proteomics to describe molecular mechanisms of congenital myasthenic syndromes (CMS) aiming the development of new therapies and the increase of effectiveness of current treatments.

Funder: HEALTH AND CONSUMPTION COUNCIL

File number: PI-0273-2024

Execution time: 28/11/2024 - 29/11/2027

IP: MARIA DEL CARMEN HERNANDEZ VALLADARES

Study of the prognostic and therapeutic value of the HSD17B family enzymes involved in estrone synthesis in patients with estrogen receptor-positive breast cancer

Funder: PUBLIC FOUNDATION FOR BIOSANITARY RESEARCH OF ORIENTAL ANDALUCIA ALEJANDRO OTERO (FIBAO)

File number: INTRAIBS-2022-07

Execution time: 20/01/2023 - 19/01/2024

IP: MANUEL PICON RUIZ

PROTEOMIC AND METABOLOMIC CHARACTERIZATION OF THE RESPONSE TO INTRAMUSCULAR INFUSION OF AUTOLOGOUS BONE MARROW STEM CELLS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) FOR THE ESTABLISHMENT OF QUANTIFIABLE BIOMARKERS PREDICTIVE OF RESPONSE

Funder: UNIVERSITY OF GRANADA

File number: C-CTS-177-UGR23

Execution time: 01/01/2024 - 31/12/2026

IP: MARIA DEL CARMEN HERNANDEZ VALLADARES

Generation of a New Humanized Pompe Disease Model for Improved Robus Preclinical Evaluation of New Pompe Therapeutics

Funder: SPARK THERAPEUTICS, INC.

File number: SPARK-2022-0002

Execution time: 24/02/2023 - 24/02/2025

IP: FRANCISCO JAVIER MOLINA ESTEVEZ

Precision genetics to tackle pancreatic cancer chemoresistance

Funder: SPANISH ASSOCIATION AGAINST CANCER

File number: LABAE234749ZAFR

Execution time: 02/10/2023 - 01/10/2026

IP: MARIA PAZ DE LA ZAFRA MARTIN

Stem-Itruck: Next Generation Car-T Cells for the Safe and Effective Treatment of Solid Tumors

Funder: DEPARTMENT OF UNIVERSITY, RESEARCH AND INNOVATION

File number: ProyExcel_00373

Execution time: 01/01/2023 - 31/12/2025

IP: VERONICA AYLLON CASES

Generation of 4th generation inducible CAR-T cells for the treatment of HER2+ positive solid tumors.

Funder: CARLOS III HEALTH INSTITUTE - FEDER

File number: PMPTA22/00060

Execution time: 01/01/2023 - 31/12/2024

IP: FRANCISCO MARTIN MOLINA

Clinical impact of digital and 3D printed models based on CT and MRI fusion in pancreatic oncological surgery (DIGIPanCa)

Funder: STATE RESEARCH AGENCY

File number: TED2021-132438B-I00

Execution time: 01/12/2022 - 30/11/2024

PI: JUAN ANTONIO MARCHAL CORRALES

Spanish Network of Advanced Therapies (TERAV)

Funder: CARLOS III HEALTH INSTITUTE - FEDER

File number: RD21 / 0017/0004

Execution time: 01/01/2022 - 31/12/2024

IP: FRANCISCO MARTIN MOLINA

NABIHEAL – ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING (NABIHEAL)

Funder: EUROPEAN COMMISSION

File number: 101092269

Execution time: 01/01/2023 - 31/12/2026

PI: JUAN ANTONIO MARCHAL CORRALES

Lymph and plasma extracellular vesicles as an alternative for the detection of mutations in breast cancer (BC-LinfaExOmic)

Funder: COUNCIL OF HEALTH AND FAMILIES

File number: PEMP-0205-2020

Execution time: 28/10/2021 - 27/10/2023

PI: JUAN ANTONIO MARCHAL CORRALES

Development and validation of a portable multimodular device for biomanufacturing and in situ repair of injured tissues (BioPen4Reg)

Funder: CARLOS III HEALTH INSTITUTE - FEDER

File number: DTS21 / 00098

Execution time: 01/01/2022 - 31/12/2023

PI: JUAN ANTONIO MARCHAL CORRALES

Development of decellularized biomimetic matrices with application in breast cancer models.

Funder: PUBLIC FOUNDATION FOR BIOSANITARY RESEARCH OF ORIENTAL ANDALUCIA ALEJANDRO OTERO (FIBAO)

File number: INTRAIBS-2020-10

Execution time: 01/01/2021 - 31/12/2021

IP: GEMA JIMENEZ GONZALEZ

HUMAN MICROBIOTA REFERENCE LABORATORY: Station for handling microorganisms in anaerobiosis and accessories for the optimization and harmonization of the phenotypic and genotypic analysis of the microbiota and its impact on nutrition and health.

Funder: COUNCIL OF ECONOMIC TRANSFORMATION, INDUSTRY, KNOWLEDGE AND UNIVERSITIES

File number: IE19_198 UGR

Execution time: 29/12/2020 - 29/12/2022

PI: MARGARITA AGUILERA GOMEZ

INFLUENCE OF ENDOCRINE DISRUPTERS CHEMICALS ON GUT MICROBIOTE: A MISSED LINK IN CHILDHOOD OBESITY (ENDOMICROMICS)

Funder: CARLOS III HEALTH INSTITUTE - FEDER

File number: PI20 / 01278

Execution time: 01/01/2021 - 31/12/2023

PI: MARGARITA AGUILERA GOMEZ

06-00001257-15 - FIPSE2015 - MARIA ANGEL GARCIA CHAVES - Method and means of isolation and enrichment of cancer stem cells with diagnostic and therapeutic utility in oncology

Funder: FOUNDATION FOR INNOVATION AND PROSPECTIVE IN HEALTH IN SPAIN

File number: 06-00001257-15

Execution time: 27/01/2016 - 26/07/2016

IP: MARIA ANGEL GARCIA CHAVES

Development of a Nanodiagnostic System Based on Myrnas / Exosomes Characteristic of Cancer Stem Cells with Prognostic and Predictive Value in Patients With Malignant Melanoma (Nanomir Melstem)

Funder: FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD

File number: PI-0533-2014

Execution time: 31/07/2015 - 01/08/2017

PI: JUAN ANTONIO MARCHAL CORRALES

PI-0441-2014 - Predictive Value of Pkr Kinase and Its Regulators in Patients With Metastatic Colon Cancer

Funder: FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD

File number: PI-0441-2014

Execution time: 01/08/2015 - 31/07/2017

IP: MARIA ANGEL GARCIA CHAVES

Drug development against tumor stem cells (CSCs) by screening synthetic libraries using GPCRs, kinases and the calcineurin-NFAT interaction as targets

Funder: MINISTRY OF ECONOMY AND COMPETITIVENESS

File number: RTC-2015-3386-1

Execution time: 01/09/2015 - 31/12/2017

PI: JUAN ANTONIO MARCHAL CORRALES

Prospective validation study of biomarkers of response to chemotherapy and therapies

Funder: CARLOS III HEALTH INSTITUTE - FEDER

File number: DTS15 / 00174

Execution time: 01/01/2016 - 31/12/2017

IP: MARIA ANGEL GARCIA CHAVES

Preclinical evaluation of safety and efficacy of a synthetic compound (MEGR756) and a compound of natural origin (MDN90) with selective activity against cancer stem cells

Funder: UNIVERSITY OF GRANADA

File number: UGR003 / B-16

Execution time: 01/01/2017 - 31/12/2018

PI: JUAN ANTONIO MARCHAL CORRALES

SMART OLIVE OIL NANOCAPSULES FOR ORAL ADMINISTRATION OF DRUGS AGAINST PANCREATIC CANCER STEM CELLS

Funder: MINISTRY OF ECONOMY AND COMPETITIVENESS

File number: MAT2015-63644-C2-2-R

Execution time: 01/01/2016 - 31/12/2018

PI: JUAN ANTONIO MARCHAL CORRALES

Potentiation of the action of ultrasound chemotherapy

Funder: UNIVERSITY OF GRANADA

File number: UGR002 / B-16

Execution time: 01/01/2017 - 31/12/2018

PI: JUAN ANTONIO MARCHAL CORRALES

HOKD TOXIN AS A NEW THERAPEUTIC TOOL AGAINST CANCER STEM CELLS DERIVED FROM PATIENTS WITH UTERAL CANCER

Funder: MUTUA MADRILEÑA FOUNDATION

File number: FMM-AP16683-2017

Execution time: 01/07/2017 - 31/12/2019

IP: HOURIA BOULAIZ TASSI

MUS4CT: Ultrasound Mechanotransduction for Improving Cancer Treatment

Funder: CARLOS III HEALTH INSTITUTE - FEDER

File number: DTS17 / 00087

Execution time: 01/01/2018 - 31/12/2019

PI: JUAN ANTONIO MARCHAL CORRALES

IMPLEMENTATION OF A NOVEL PLATFORM TO MONITOR TUMOR HETEROGENEITY AS A CRUCIAL DETERMINANT FOR INDIVIDUALIZED DIAGNOSTIC AND THERAPEUTIC OUTCOME

Funder: CARLOS III HEALTH INSTITUTE - FEDER

File number: PIE16 / 00045

Execution time: 01/01/2017 - 31/12/2019

PI: JUAN ANTONIO MARCHAL CORRALES

Development of bioprinting and biotin systems for three-dimensional cartilage and bone regeneration

Funder: MINISTRY OF ECONOMY AND COMPETITIVENESS

File number: RTC-2016-5451-1

Execution time: 01/01/2017 - 31/12/2019

PI: JUAN ANTONIO MARCHAL CORRALES

Development of a New Gene Therapy Tool Based on the Use of Ldrb Toxin Targeting Cancer Stem Cells Derived from Breast and Colon Cancer Patients.

Funder: COUNCIL OF HEALTH

File number: PI-0089-2017

Execution time: 01/01/2018 - 31/12/2020

IP: HOURIA BOULAIZ TASSI

BIOINKS 4 3D-SKIN: New biotinks for 3D bioprinting of skin grafts and malignant melanoma models

Funder: CARLOS III HEALTH INSTITUTE - FEDER

File number: DTS19 / 00143

Execution time: 01/01/2020 - 31/12/2021

PI: JUAN ANTONIO MARCHAL CORRALES

OBEMIRISK-Knowledge platform for assessing the risk of Biosphenols on gut microbiota and its role in obesogenic phenotype: looking for biomarkers,

Funder: EFSA EUROPEAN FOOD SAFETY AUTHORITY

File number: GP / EFSA / ENCO / 2018/03 - GA04

Execution time: 05/12/2018 - 01/05/2021

PI: MARGARITA AGUILERA GOMEZ

OncoBreast3DPrint: BIOPRINTED MIMETIC TUMOR MODELS OF BREAST CANCER USEFUL IN PRECISION ONCOLOGY

Funder: COUNCIL OF HEALTH AND FAMILIES

File number: PIN-0224-2019

Execution time: 01/01/2020 - 31/12/2022

IP: GEMA JIMENEZ GONZALEZ

IDENTIFICATION OF THE PATHOPHYSIOLOGICAL ROLE OF THE MICROBIOTA ALTERED BY DIETARY XENOBIOTICS IN PATIENTS WITH HORMONAL DISORDERS - REFERENCE LABORATORY

Funder: MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES

File number: EIN2019-103082

Execution time: 01/11/2019 - 30/06/2021

PI: MARGARITA AGUILERA GOMEZ

RESEARCH INTENSIFICATION ACTIONS WITHIN THE EUROPEAN PROJECT: EFSA PARTNERING GRANT-GA04: OBEMIRISK

Funder: UNIVERSITY OF GRANADA

File number: INT-14

Execution time: 01/11/2019 - 30/06/2021

PI: MARGARITA AGUILERA GOMEZ

3D bioprinting of cartilage and bone with decellularized matrix-based biotin (dECM) for the regeneration of osteochondral lesions

Funder: MUTUA MADRILEÑA FOUNDATION

File number: FMM-AP17196-2019

Execution time: 01/07/2019 - 30/06/2022

PI: ELENA LOPEZ RUIZ

facebook icon twitter icon LinkedIn icon whatsapp icon

Responsible researcher

JUAN ANTONIO MARCHAL CORRALES

  • jmarchal@ugr.es
  • More Information
  • ORCID

Responsible Co-Investigator

HOURIA BOULAIZ TASSI

  • hboulaiz@ugr.es
  • ORCID

Research

  • Publications Search
  • Collaboration network between groups of the ibs.GRANADA
  • Oncology Area
  • Epidemiology and Public Health Area
  • Precision Medicine Area
  • Advanced Therapies and Biomedical Technologies Area
  • Clinical Trials Platform

Post navigation

TEC15-Nuclear and Molecular Medicine
TEC17-Biotejsalud

ibs.Granada logo

  • info@ibsgranada.es
  • Avda. De Madrid, 15
    External Consultation Pavilion, 2nd Floor
    18012 Grenada.
  • facebook icon
  • twitter icon
  • instagram icon
  • linkedin icon
  • youtube icon
University of Granada
Investigate +
© 2026 ibs.GRENADA
  • Legal Notice
  • Cookies Policy
  • Privacy Policy
  • Contact
  • Site map

This website, managed by FIBAO, uses its own and third-party cookies to obtain statistical data and create browsing profiles. More information in our Cookies policy.

X
ibs logo.GRANADA
Powered by  GDPR Cookie Compliance
Privacy summary

This website uses cookies so that we can offer you the best possible user experience. The information of the cookies is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful.

Technical and necessary cookies

The strictly necessary cookies must always be activated so that we can save your cookie settings preferences.

Analytics and optimization

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, or the most popular pages.

Leaving this cookie active allows us to improve our website.

Cookie policy

More information about our Cookies policy